scholarly journals A comprehensive study capturing vision loss burden in Pakistan (1990-2025): Findings from the Global Burden of Disease (GBD) 2017 study

PLoS ONE ◽  
2019 ◽  
Vol 14 (5) ◽  
pp. e0216492 ◽  
Author(s):  
Bilal Hassan ◽  
Ramsha Ahmed ◽  
Bo Li ◽  
Ayesha Noor ◽  
Zahid ul Hassan
2020 ◽  
Vol 5 (12) ◽  
pp. e682-e691
Author(s):  
Tingling Xu ◽  
Bingsong Wang ◽  
Hua Liu ◽  
Haidong Wang ◽  
Peng Yin ◽  
...  

2021 ◽  
pp. bjophthalmol-2021-319603
Author(s):  
Guangming Jin ◽  
Minjie Zou ◽  
Chi Liu ◽  
Aiming Chen ◽  
Yi Sun ◽  
...  

PurposeTo investigate the burden of near vision loss (NVL) in China by year, age and gender from 1990 to 2019.MethodsWe used estimates from the Global Burden of Disease (GBD) 2019 study to report the prevalence and disability-adjusted life-years (DALYs) due to NVL in China. Estimates of crude counts and age-standardised rates per 100 000 population are accompanied by 95% uncertainty intervals (UIs). We summarised the age-specific and sex-specific patterns and trends regarding the burden of NVL in China, compared with seven neighbouring countries.ResultsFrom 1990 to 2019, the all-age number and rate for NVL prevalence and DALYs increased significantly in China (all p<0.001). The age-standardised rate decreased from 7538.1 (95% UI 6946.3 to 8075.1) to 7392.9 (95% UI 6855.8 to 7890.5) per 100 000 population for NVL prevalence (p=0.107), and from 74.9 (95% UI 69.6 to 79.9) to 73.8 (95% UI 70.6 to 80.1) per 100 000 population for DALYs (p=0.388). Women had higher NVL prevalence (t=170.1, p<0.001) and DALYs (t=192.5, p<0.001) than men. Higher disease burden of NVL was observed in the middle-aged and elderly population. The age-standardised prevalence and DALY rate attributable to NVL in China were lower than in India, North Korea, Pakistan (all p<0.001), but higher than Russia, South Korea, Singapore and Japan (all p<0.001).ConclusionsDespite a small decrease in age-standardised prevalence and DALYs due to NVL in China in the past two decades, the existing burden is still considerable and significantly higher compared with neighbouring developed countries. An approach that includes all stakeholders is needed to further reduce this burden.


BMJ Open ◽  
2022 ◽  
Vol 12 (1) ◽  
pp. e053805
Author(s):  
Yi Sun ◽  
Aiming Chen ◽  
Minjie Zou ◽  
Yichi Zhang ◽  
Ling Jin ◽  
...  

ObjectiveTo estimate global prevalence of blindness and vision loss caused by glaucoma, and to evaluate the impact of socioeconomic factors on it.DesignA population-based observational study.SettingThe prevalence of blindness and vision loss due to glaucoma were obtained from the Global Burden of Disease Study 2017 database. The Human Development Index (HDI), inequality-adjusted HDI and other socioeconomic data were acquired from international open databases.Main outcome measuresThe prevalence of blindness and vision loss due to glaucoma by age, gender, subregion and Socio-Demographic Index (SDI) levels. Multiple linear regression analysis was performed to explore the associations between the prevalence and socioeconomic indicators.ResultsThe overall age-standardised prevalence of blindness and vision loss due to glaucoma worldwide was 81.5 per 100 000 in 1990 and 75.6 per 100 000 in 2017. In 2017, men had a higher age-standardised prevalence than women (6.07% vs 5.42%), and the worldwide prevalence increased with age, from 0.5 per 100 000 in the 45–49 year age group to 112.9 per 100 000 among those 70+. Eastern Mediterranean and African regions had the highest prevalence during the whole period, while the Americas region had the lowest prevalence. The prevalence was highest in low-SDI and low-income regions while lowest in high-SDI and high-income regions over the past 27 years. Multiple linear regression showed cataract surgery rate (β=−0.01, p=0.009), refractive error prevalence (β=−0.03, p=0.024) and expected years of schooling (β= -8.33, p=0.035) were associated with lower prevalence, while gross national income per capita (β=0.002, p<0.001) was associated with higher prevalence.ConclusionsLower socioeconomic levels and worse access to eyecare services are associated with higher prevalence of glaucoma-related blindness and vision loss. These findings provide evidence for policy-makers that investments in these areas may reduce the burden of the leading cause of irreversible blindness.


2020 ◽  
Vol 4 (Supplement_1) ◽  
pp. 808-808
Author(s):  
Jaimie Adelson ◽  
Paul Briant ◽  
Seth Flaxman ◽  
Hugh Taylor ◽  
Serge Resnikoff ◽  
...  

Abstract The Global Burden of Disease study estimates the prevalence of vision loss by WHO severity group, and the distribution of vision loss due to underlying causes such as cataract, glaucoma, and uncorrected refractive error. Data sources include national and local surveys, and scientific literature, with over 500 sources in 113 countries. Cause-specific prevalence estimates were proportionally fit into estimates of total vision loss by severity. Globally, 821.9 million (95% UI=682.2–970.4) people experienced moderate or worse distance vision loss or near vision loss in 2019 (age-standardized prevalence = 0.10, UI=0.08–0.12). Of these, 41.9 million (UI=36.4–46.8) were blind. The majority of Years Lived with Disability due to vision loss occurred in people with cataract and uncorrected refractive error. Vision loss numbers will continue to increase due to aging populations. Main causes of vision loss are correctable and, therefore, should be major targets of interventions.


Sign in / Sign up

Export Citation Format

Share Document